CCL2 and cancer: Drugs that block the chemokine monocyte chemoattractant protein 1 (MCP-1 or CCL2) downstream of TWEAK can significantly reduce the growth of CCA xenografts, while TWEAK overexpression promotes the proliferation and collagen deposition of cancer-associated fibroblasts.